Quality Assured
Supplied across India with dependable dispatch.
Moxicak 625 LB
Amoxicillin, Clavulanate Potassium & Lactic Acid Bacillus Tablets
Moxicak 625 LB is a gold-standard broad-spectrum antibiotic enhanced with Potassium Clavulanate to overcome beta-lactamase resistance, plus Lactic Acid Bacillus to safeguard gut microflora against antibiotic-associated diarrhea.
Product Specifications
| Composition | Each film coated tablet contains: Amoxicillin Trihydrate IP eq. to Amoxicillin 500 mg + Potassium Clavulanate IP eq. to Clavulanic Acid 125 mg + Lactic Acid Bacillus 60 Million Spores |
| Pack Size | 10 x 10 Tablets |
| Dosage Form | Tablet |
| Storage | Store in a cool, dry place below 30°C. Protect from light. |
Therapeutic Indications
Key Formulation USPs
- Overcomes beta-lactamase bacterial resistance effectively
- Enriched with 60 Million Spores of gut-friendly Lactic Acid Bacillus
- Prevents antibiotic-induced gastrointestinal disturbance and dysbiosis
- Broad-spectrum bactericidal coverage for stubborn infections
- Superior Alu-Alu foil with specialized desiccant barrier
Frequently Asked Questions About Moxicak 625 LB
Essential product details, active salt composition, dosage specifications, and PCD franchise distribution queries answered.
Moxicak 625 LB is a pharmaceutical tablet containing Amoxicillin, Clavulanate Potassium & Lactic Acid Bacillus Tablets. It is manufactured by Medizons International Pvt. Ltd. and primarily indicated for Lower Respiratory Tract Infections (Severe Bronchitis, Pneumonia), ENT Infections (Otitis Media, Sinusitis, Tonsillitis), Skin and Soft Tissue Infections, Dental Infections and Abscesses, Bone and Joint Infections.
Related Medicines
TabletAntibiotics